The Global Forum for Vaccine and Immunization Research (GVIRF)
The GVIRF is a unique Forum in the field of vaccines & immunization. It is the central discussion platform of all research aspects related to the Global Vaccine Action Plan (GVAP), which was developed in the context of the Decade of Vaccines Collaboration and endorsed by the 2012 World Health Assembly. The GVIRF is co-hosted by WHO, the National Institute of Allergy and Infectious Diseases, and the Bill & Melinda Gates Foundation. Gathering leading experts from public health, academia, government, civil society and private sector, the forum is held every second year.
The overall objective of the GVIRF is to serve as a forum to:
- track progress and discuss obstacles related to priority vaccine research and development;
- identify gaps, opportunities and actions for the research and development (R&D) community in the areas of vaccines and immunization;
- create an opportunity for networking and collaboration among the vaccine R&D and immunization communities; and
- review progress towards GVAP research and development strategic objectives and goals.
As endorsed by the Decade of Vaccines Collaboration Leadership Council and the WHO Strategic Advisory Group of Experts (SAGE), research reporting for the GVAP is conducted every two years by the GVIRF with emphasis on:
- expanding capabilities of engagement with end-users,
- enabling development of new vaccines,
- accelerating development, licensing and update of vaccines, and
- improving programme efficiencies and increasing coverage.